HYPERION DEFI, INC.

HYPD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2021 FY2020
Revenue $813.5K $57.3K $3.8K $14.0M $2.0M
Cost of Revenue $303.3K $3.9M $16.0K $1.6M $800.0K
Gross Profit $510.2K $-3.9M $-12.2K $12.4M $1.2M
Gross Margin 62.7% -6,749.5% -322.6% 88.6% 60.0%
Operating Expenses
Research & Development $1.9M $14.5M $13.0M $14.9M $13.4M
SG&A Expense $17.2M $14.3M $12.4M $10.6M $7.6M
Operating Income $-46.7M $-48.7M $-25.4M $-13.0M $-19.8M
Operating Margin -5,743.5% -85,004.6% -670,885.8% -93.0% -989.5%
Interest Expense $380.0K $2.4M $387.8K $17.0K
Pretax Income
Income Tax Expense $-30.9K
Net Income $-45.3M $-49.8M $-27.3M $-12.8M $-19.8M
Net Margin -5,570.6% -86,888.6% -719,859.9% -91.3% -988.5%
EPS (Basic) $-9.40 $-9.97 $-8.86 $-0.08 $-0.16
EPS (Diluted) $-9.40 $-9.97 $-8.86 $-0.08 $-0.16
Shares Outstanding (Basic) 5.0M 5.0M 3.1M 157.9M 126.3M
Shares Outstanding (Diluted) 5.0M 5.0M 3.1M 157.9M 126.3M
Dividends Per Share